Lawrence J. McQuillan
Business & Economics
Tort Tally 2009
The Pacific Research Institute (PRI), a free-market think tank based in California, today released Tort Law Tally, a new report identifying which state tort reforms reduce tort losses and tort insurance premiums the most. The analysis identifies 18 reforms to state civil-justice systems that significantly reduce tort losses and/or tort ...
Business & Economics
California Enterprise Value Index
The California Enterprise Value Index is a measure of the enterprise value (EV) of publicly traded companies headquartered in California relative to the EV of all U.S. publicly traded companies. This is the first measure in an ongoing series. “The Index is a barometer of the relative underperformance or overperformance ...
Business & Economics
Tort Law Tally – Letters, faxes, and e-mail
The ascendancy of Barack Obama has emboldened the Association of Trial Lawyers of America, now repackaged as the American Association for Justice. Recently, the trial lawyers sent the Obama team their 2009 legislative “wish list” as part of a broader strategy to expand litigation and deny that lawsuit reform cuts ...
Business & Economics
Suits hurt consumers
Making it easier to sue drug and medical-device manufacturers won’t help patients, contrary to what Milton Younger claims in a recent Community Voices article (“Put FDA back to work for consumers,” April 21). Instead, such federal legislation would unleash a torrent of meritless state lawsuits to the detriment of public ...
Business & Economics
Tort Law Tally
San Francisco – The Pacific Research Institute (PRI), a free-market think tank based in California, released Tort Law Tally, a new report identifying which state tort reforms reduce tort losses and tort insurance premiums the most. The analysis identifies 18 reforms to state civil-justice systems that significantly reduce tort losses ...
Business & Economics
Putting Drug Research in Legal Jeopardy
The U.S. Supreme Court’s recent ruling in Wyeth v. Levine—holding that drug manufacturers are not free of liability under state law, even when the drug in question has secured federal regulatory approval—has worried pharmaceutical manufacturers, who can now face crippling state tort lawsuits despite being in regulatory compliance. A less-noticed ...
Business & Economics
Liability system is unreliable
Washington Times, March 26, 2009 It is encouraging that President Barack Obama and congressional leaders seem serious about reforming our destructive medical-malpractice liability system (“Medical malpractice reform eyed in health care debate,” March 17). Such action would do wonders to lower health care costs and improve patient access to care. ...
Business & Economics
Don’t hold drugmakers liable for competitors’ generics
The California Supreme Court’s recent decision not to review Conte vs. Wyeth leaves name-brand drug manufacturers liable for harm caused by another manufacturer’s generic version of its drug. This unprecedented and unfair extension of product liability spells bad news for innovators and consumers alike. Plaintiff Elizabeth Conte took a generic ...
Business & Economics
California Supreme Court Decision Quashes Innovation, Threatens Health, and Encourages Costly Lawsuit Abuse
Traditional tort law holds that manufacturers are responsible only for their own products, not those made by competitors. The California Supreme Court changed that in late January by declining to review Conte v. Wyeth, which leaves name-brand drug manufacturers liable for harm caused by another manufacturer’s generic version. This unprecedented ...
Business & Economics
Governor’s Entrepreneurship Conference offers recommendations
To find out which state policies California’s small-business owners would like to change, Gov. Arnold Schwarzenegger recently convened a two-day conference in Los Angeles. Greater government dependency and intervention will reduce innovation, economic growth and job creation. Or, as Albert Einstein said, “Bureaucracy is the death of all sound work.” ...
Tort Tally 2009
The Pacific Research Institute (PRI), a free-market think tank based in California, today released Tort Law Tally, a new report identifying which state tort reforms reduce tort losses and tort insurance premiums the most. The analysis identifies 18 reforms to state civil-justice systems that significantly reduce tort losses and/or tort ...
California Enterprise Value Index
The California Enterprise Value Index is a measure of the enterprise value (EV) of publicly traded companies headquartered in California relative to the EV of all U.S. publicly traded companies. This is the first measure in an ongoing series. “The Index is a barometer of the relative underperformance or overperformance ...
Tort Law Tally – Letters, faxes, and e-mail
The ascendancy of Barack Obama has emboldened the Association of Trial Lawyers of America, now repackaged as the American Association for Justice. Recently, the trial lawyers sent the Obama team their 2009 legislative “wish list” as part of a broader strategy to expand litigation and deny that lawsuit reform cuts ...
Suits hurt consumers
Making it easier to sue drug and medical-device manufacturers won’t help patients, contrary to what Milton Younger claims in a recent Community Voices article (“Put FDA back to work for consumers,” April 21). Instead, such federal legislation would unleash a torrent of meritless state lawsuits to the detriment of public ...
Tort Law Tally
San Francisco – The Pacific Research Institute (PRI), a free-market think tank based in California, released Tort Law Tally, a new report identifying which state tort reforms reduce tort losses and tort insurance premiums the most. The analysis identifies 18 reforms to state civil-justice systems that significantly reduce tort losses ...
Putting Drug Research in Legal Jeopardy
The U.S. Supreme Court’s recent ruling in Wyeth v. Levine—holding that drug manufacturers are not free of liability under state law, even when the drug in question has secured federal regulatory approval—has worried pharmaceutical manufacturers, who can now face crippling state tort lawsuits despite being in regulatory compliance. A less-noticed ...
Liability system is unreliable
Washington Times, March 26, 2009 It is encouraging that President Barack Obama and congressional leaders seem serious about reforming our destructive medical-malpractice liability system (“Medical malpractice reform eyed in health care debate,” March 17). Such action would do wonders to lower health care costs and improve patient access to care. ...
Don’t hold drugmakers liable for competitors’ generics
The California Supreme Court’s recent decision not to review Conte vs. Wyeth leaves name-brand drug manufacturers liable for harm caused by another manufacturer’s generic version of its drug. This unprecedented and unfair extension of product liability spells bad news for innovators and consumers alike. Plaintiff Elizabeth Conte took a generic ...
California Supreme Court Decision Quashes Innovation, Threatens Health, and Encourages Costly Lawsuit Abuse
Traditional tort law holds that manufacturers are responsible only for their own products, not those made by competitors. The California Supreme Court changed that in late January by declining to review Conte v. Wyeth, which leaves name-brand drug manufacturers liable for harm caused by another manufacturer’s generic version. This unprecedented ...
Governor’s Entrepreneurship Conference offers recommendations
To find out which state policies California’s small-business owners would like to change, Gov. Arnold Schwarzenegger recently convened a two-day conference in Los Angeles. Greater government dependency and intervention will reduce innovation, economic growth and job creation. Or, as Albert Einstein said, “Bureaucracy is the death of all sound work.” ...
